文献速递临床试验与 GCP医学教育与科研方法真实世界研究与卫生经济

通过个体化与小组化治疗性患者教育项目强化2型糖尿病照护:一项整群随机试验的研究方案

Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial.
PubMed 文献 · Trials · 2025-12-23

该研究为在瑞士日内瓦州开展的多中心整群随机对照试验,计划纳入至少154例新诊断2型糖尿病患者,来自约30家初级保健医生诊所,按1:1随机分为干预组和对照组。干预组由初级保健医生及相关卫生专业人员接受治疗性患者教育要素培训,患者制定个体化治疗计划并定期收集患者报告结局指标;对照组接受标准照护。主要终点为12个月时HbA1c平均变化,次要终点包括18个月HbA1c变化、患者报告结局、医学结局及成本效果。

要点

  • 干预组患者接受由多学科团队制定的个体化治疗计划,并定期收集患者报告结局指标。
  • 主要终点为12个月时HbA1c平均变化,次要终点包括18个月HbA1c变化及患者报告结局等。
  • 研究在瑞士日内瓦州约30家初级保健医生诊所开展,计划纳入至少154例新诊断2型糖尿病患者。

核心结论

  • 若研究获得阳性评价,可为该2型糖尿病项目在瑞士的推广提供依据,并可能成为改善2型糖尿病患者健康结局的基石。

研究设计与样本

  • 研究为在瑞士西部日内瓦州开展的多中心整群随机对照试验。
  • 计划纳入至少154例新诊断2型糖尿病患者,来自约30家初级保健医生(PCP)诊所。
  • 诊所按1:1的患者分配比例,采用协变量约束随机化分为干预组或对照组。
  • 干预持续12个月,随访6个月。

关键数值与推荐

  • 主要终点为12个月时HbA1c水平的平均变化。
  • 次要终点包括18个月时HbA1c水平的平均变化、12个月和18个月时患者报告结局(EQ-5D-5L、DIAB-Q)的平均变化、医学结局(血压、身体成分、用药)的平均变化以及患者体验。
  • 进一步从支付方角度评估成本效果。

临床怎么用

  • 干预组:初级保健医生及相关卫生专业人员(如营养师、物理治疗师)接受专家关于治疗性患者教育要素的跨专业小组培训。
  • 干预组:患者与初级保健医生、其他卫生专业人员、治疗性患者教育专家、专职研究管理者及其他患者在一个初始质量圈中制定个体化治疗计划。
  • 干预组:治疗计划伴随定期患者报告结局指标(PROM)收集,并在患者常规初级保健医生访视中讨论。
  • 对照组:患者接受标准照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Type 2 diabetes (T2D) presents a significant challenge to health systems and its prevalence is projected to increase. T2D is significantly influenced by lifestyle factors, including diet and physical activity. This makes therapeutic patient education (TPE) a pivotal component of T2D treatment strategies. While in some countries, like Germany and the UK, TPE elements like physician counselling regarding lifestyle changes (e.g., nutrition, smoking, exercise) and participation in diabetes education courses are part of structured nationwide disease management programs; in Switzerland, TPE elements are rarely part of the standard of care protocols. Our goal is to evaluate whether an interdisciplinary and individualized T2D program including TPE elements improves patients' health outcomes. METHODS: The study is a multi-center cluster randomized controlled trial in the canton of Geneva in Western Switzerland. We aim to include a minimum of 154 recently diagnosed T2D patients from around 30 primary care physician (PCP) practices. Practices are randomized with a 1:1 patient allocation ratio to either intervention or control group using covariate constrained randomization. The intervention lasts 12 months with a 6-month follow-up and consists of two steps. First, PCPs in the intervention group and associated healthcare professionals (e.g., dieticians, physical therapists) are trained in interprofessional group sessions on TPE elements by specialists. Second, patients follow an individualized treatment plan which is designed within an initial quality circle with their PCP, other healthcare professionals, a TPE specialist, a dedicated study manager, and other patients. The treatment plan is accompanied by regular patient-reported outcome measure (PROM) collections, which are discussed in patients' regular PCP visits. Patients in the control group follow standard of care. Primary endpoint is the 12 months mean change in HbA1c levels, secondary endpoints are the 18 months mean change in HbA1c levels, the 12 and 18 months mean changes in patient-reported outcomes (EQ-5D-5L, DIAB-Q), mean changes in medical outcomes (blood pressure, body composition, medication intake), and patient experience. We further evaluate cost-effectiveness from the payer perspective. DISCUSSION: A positive evaluation of the study can inform a wider roll-out of the T2D program within Switzerland and be a cornerstone for better patient health outcomes for T2D patients. TRIAL REGISTRATION: ClinicalTrials.gov: NCT06774950. Registered on 14 January 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ehlig D, Sapin M, Zeukeng MJ, et al. Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study protocol for a cluster randomized trial. Trials. 2025. PMID: 41437100. doi:10.1186/s13063-025-09302-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。